Olivia Newton-John faces her third cancer battle

Australian icon and music legend Olivia Newton-John has lately opened up to the media about her ongoing 27 year battle with cancer and how she uses a lot of cannabis in her healing.

 

Diagnosed with breast cancer back in 1992, Newton-John announced in 2018 that a tumour had returned to her back. She also recently revealed a second bout of cancer that surfaced in her shoulder in 2013, USA Today reported.

According to the article, Newton-John has credited having a positive attitude in her ongoing struggle: “I had to make a decision that no matter what, I was going to be OK," she said. "My main decision was, I’m going to get better, and I have a young child (daughter Chloe Rose Lattanzi, now 33) to raise," USA Today reported.

With an indomitable spirit, Newton-John spoke about her husband John Easterling, 66, a natural health entrepreneur, with helping her feel better every day.

At their southern California ranch, “My husband hands me all these herbs every morning and makes me a green algae drink,” she says. And a proponent of medicinal cannabis, “He grows the plants and makes them into liquid for me. I take drops maybe four to five times a day,” People Magazine reported. Although initially nervous about trying medicinal cannabis, she stated that “it has helped incredibly with pain maintenance and sleep.”

“You don’t die from cannabis yet we have a terrible opiate problem in the world – people dying of opiates. Cannabis can take the place of opiates and people will not be dying,” Newton-John told The New Daily.

Currently, there is a huge surge in medical and scientific research into the efficacy of medicinal cannabis for use in pain management with many encouraging results emerging. At the forefront of cannabis research is Israel, with its Tikkun Olam research department revealing statistical analyses from a recent study that after six months of treatment with cannabis, patients reported significant reduction in pain levels and improvement in quality of life and a perception that the treatment was effective for their condition, Forbes reported.

Clearly, there is much work and research left to be done in this arena.

Be the first to comment

Please check your e-mail for a link to activate your account.

Join the newsletter

connect

get updates